✉news BusinessStartups first seen 9 h ago, last 2 h ago, peak #13
Celaid Therapeutics raises $2.6 million in Series B extension
Original: Japanese startup Celaid Therapeutics completes second close of Series B financing round with $2.6 M
Japanese biotech startup Celaid Therapeutics has completed the second close of its Series B financing round, bringing in an additional $2.6 million. The company, which is developing regenerative medicine therapies, did not disclose the investors involved. The funding will support its push to advance its cell-based treatment pipeline, though specific allocation details were not announced.
Why now: Funding news in the biotech startup sector draws attention from investors and industry watchers tracking Japan's regenerative medicine field.
Rank over time, top of the chart is #1. 5 snapshots from 9 h ago to 2 h ago.
Evidence
- Japanese startup Celaid Therapeutics completes second close of Series B financing round with $2.6 M · BioSpectrum Asia
API: https://socialmediatrends-api.osmike.com/v1/trends/1100296